Shuttle Pharmaceuticals Holdings (SHPH) Total Current Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 366.04% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 366.04% YoY), while the FY2025 annual figure was $8.0 million, up 419.43% from the prior year.
• Total Current Liabilities was $8.3 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $8.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $8.3 million in Q1 2026 to a low of $493682.0 in Q2 2023.
• Historically, Total Current Liabilities has averaged $2.2 million across 5 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 56.0% in 2022, then surged 419.43% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $975676.0 in 2022, then advanced by 6.82% to $1.0 million in 2023, then jumped by 47.16% to $1.5 million in 2024, then soared by 419.43% to $8.0 million in 2025, then climbed by 4.25% to $8.3 million in 2026.
• The last three Total Current Liabilities figures came in at $8.3 million (Q1 2026), $8.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.